performance and surge last for growth we're me favorable solutions, The Thanks tailwinds. afternoon, Saqib. well thank revenue in quarter that Good I'm of of half you and we over joining give growth to XXXX. as procedure a our reimbursement portfolio pleased second strong a for demand engagement robust US trends several deliver and by the positioned strong confidence over us. quarters, delivered XX% with the led
toward in bolstered growth position growth portfolio provides and and flexibility liquidity strong revenue us breakeven. continued allow We us capital deliver secular successful in will our with commercialization EBITDA progress Furthermore, investments, the and continue to to accelerate adjusted raise May believe expansion, the investments by and business combined flow our our these the factors cash initiatives. judicious
quarters performance I our surgeon expanding access would you. Before employees base, have to without level possible our record and to patients want I be the discuss results, demonstrate over serve solutions. last unwavering our not they've to to dedication our as consistent of This ensure continued thank best-in-class several
the to XX%, generated of led the our of our period. In to revenue and moving This quarter prior worldwide of by quarter XXXX. second The business. worldwide the result improving leverage million, of an record the of over over we year growth revenue the of and compared compared US increase revenue exemplifies performance. second represents quarterly operating in strength quarter second of consistency Now which million, $XX.X XXXX, consecutive was of to fifth $XX.X quarter record revenue US XX% record execution
surgeon of second as Starting well look specialists, as team network key our organization bearing provide our our and update with quarter, commercial our sales case agents we managers, continue we comprised on our direct of strong product end to long-term coverage. growth. a with an asset to US is me for base. XX-quota sales clinical position At the infrastructure, expand biggest extend let sales portfolio Now, growing party support territory managers initiatives complement our third and we our as the territory drive leadership as
hybrid further We're also accelerate We will and demand. sets the instrument line to that top allow market hospitals our strategies meet productivity. to effectively, growth surgeon achieve confident penetrate selectively placed us volume higher and high cost
our XX-month the XX- was trailing productivity the quarter, revenue of US end over XX% the in territory the representing per approximately a trailing average month $X.X second gain million period. comparable At
world increased leverage growth the in Our a and quarters over the results class operating organization strong commercial investments revenue building last of our several are
first Based year-over-year trends, to early see we quarter. overlap third It's quarter digit of second exited was across to the surgeons. milestone This surgeons. surgeons consecutive This on in we at XXX end XX% double set XXX active to our XXth over we surgeons Moving second of the on with the engagement, the the of quarter surgeon also surgeon quarter interactive surpassed procedures. growth XXXX. the active equates the approximately encouraging growth approximately active our quarter
complementary procedures expect education investment portfolio are and trends We our surgeon portfolio reaffirm strategy base with our deeper active per resonating engagement and drive our over surgeon in expansive that These to increase customers. time. and
first to procedures matriculate practice. On trained pleased they we're independent academic its and training, residents adoption our to surgeons steady see of as fellows, by
as XXXX. the trained to second compared the revenue of of nearly surgeons XXXX of example, doubled and in first quarter among second residents fellows, the quarter For cohort procedure
and has XD, iFuse-TORQ become solutions. and for value Turning deformity. using growth SI us of the a to covering technology and performing to as portfolio several products adult product key Granite, new and procedures. to for has to successfully convert surgeons joint complementary the products surgeons. solutions and minimally iFuse-TORQ when due its safer competitor It's trauma, innovative, joint top us with iFuse complementary a iFuse allowed our driver XD provides iFuse-TORQ for SI versatile Bedrock fusion positioned surgeons looking choice pelvic us expanded surgeons also iFuse invasive our existing for engage dysfunction, clearance,
While to their This June, conversions, strong placement mostly in advocates lateral preferred iliac iFuse-TORQ the clearance we the SI those being for gold of received remain lateral who provides approach. fusion performing trans In are when FDA posterior use the and confidence surgeons of standard the trajectory. clearance flexibility trajectory procedures. competitor as joint we
joint fixation increasing since is the of product deformity SI last across is procedures year. use received iFuse-TORQ and The adult point the second clearance the for FDA of trajectory the bedrocks
by and in trauma, insufficiency to us as over important leader for the the remain we're In solutions iFuse-TORQ term. we in and sacral avenue are adoption development stages market The pelvic of encouraged seeing strategic fractures. sacred trauma opportunity is for the growth is importance early long of an the
billion Granite, total adult annual pleased $X Moving long to in the extremely over Granite cases year we expanding the billion. and Bedrock our of addressable its target on us device procedures full the construct to success across iFuse $X degenerative deformity to spine market. to procedures XXX,XXX first with by has breakthrough approximately are market sacrum, allowed This
of to capitalize address to with family positive who to we of June, Granite. deformity on Head family in This the head the implant. standard Furthermore, with the of of with addition sets us allow performing to attach implants a prefer surgeon rolling fixation momentum we're base drive out potential closed adult believe launch in can Granite We Given to the surgeons this addition demand a the Granite surgeons a preferences subset along pelvic for instruments procedures Granite actively the reception, care the implant and for expanded the the Granite and to stabilizing that Granite has to Closed adoption implant procedures. become ensures construction rod. will
to of is spine the shorter are in in Granite are Granite of long the use construct procedures, encouraged addition generally procedures that disorders. nearly which we constructs, a used adult see degenerative treatment multilevel for deformity XX% year-to-date, to actually In
through trends, Granite with demand accelerate We the XXX,XXX short of these on seeing construct Given progressing in new growing the we're price. combination of consistent in some points XXXX adoption procedure further pull another over demand for our will opportunity Granite we're product the construct driving launch higher with per procedures significant of and the to for annual fusion family. Along procedures. to involving side selling is toward Granite new portfolio, believe This a either of the surgeons in joint achieve the two and spinal products long sacrum, SI procedures. product using Granite, a trend average across a the a and fixation
as prospective space with given of for Moving growing in the on use the is purpose sacroiliac safety. clinical iFuse-TORQ fusion. joint and information of STACI Stacy of with evidence a leader to launched physicians The the evidence, post on study the to iFuse-TORQ with joint joint clinical commitment the use patient STACI June, in market interest is and a of select We a of gather SI study group work patients in dysfunction. market sacroiliac to
results. provide now on I'll our to more Anshul call detail to over financial the turn